The immunosuppressive effects of a leukotriene B4 receptor antagonist on liver allotransplantation in rats

Surgery Today

Volumn 26, Issue 6, 1996, Pages 419-426

  Ii, Toru ^a   Izumi, Ryohei ^a   Shimizu, Koichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

immunosuppressive effects; leukotriene B4 (LTB4) receptor antagonist; liver allotransplantation in rats; ONO4057; prostaglandin E2 (PGE2)

Indexed keywords

5 [2 (2 CARBOXYETHYL) 3 [6 (4 METHOXYPHENYL) 5 HEXENYLOXY]PHENOXY]VALERIC ACID; ALANINE AMINOTRANSFERASE; BILIRUBIN; DIMETHYL SULFOXIDE; LEUKOTRIENE B4 RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PROSTAGLANDIN E1;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOLOGY; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MALE; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TISSUE LEVEL;

ALANINE TRANSAMINASE; ANIMALS; BILIRUBIN; DINOPROSTONE; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER TRANSPLANTATION; MALE; PHENYLPROPIONATES; RATS; RATS, INBRED ACI; RATS, INBRED LEW; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030008471     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00311929     Document Type: Article

References (56)

1. Calne RY, White DJG, Thiru S, Evans DB, McMaster P, Dunn DC, Graddock GN, Pentlow BD (1978) Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 2:1323-1327
2. Starzl TE, Iwatsuki S, Thiel DHV, Gartner JC, Zitelli BJ, Malatack JJ, Schade RR, Shaw BW Jr, Hakala TR, Rosenthal JT, Porter KA (1982) Evolution of liver transplantation. Hepatology 2:614-636
3. Starzl TE, Todo S, Fung J, Demetris AJ, Venkataramman R, Jain A (1989) FK506 for liver, kidney, and pancreas transplantation. Lancet II 8670:1000-1004
4. Klintmalm GBG, Iwatsuki S, Starzl TE (1981) Cyclosporin A hepatotoxicity in 66 renal allograft recipients. Transplantation 32:488-489
5. Klintmalm GBG, Iwatsuki S, Starzl TE (1981) Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet 1:470-471
6. McCauley J, Fung J, Jain A, Todo S, Starzl TE (1990) The effects of FK 506 on renal function after liver transplantation. Transplant Proc 22:17-20
7. Kumano K, Wang G, Endo T, Kuwao S (1991) FK506-induced nephrotoxicity in rats. Transplant Proc 23:512-515
8. Konishi K, Watanabe T, Yabushita K, Hirosawa H, Izumi R, Miyazaki I (1991) Effect of lipoxygenase inhibitor (nordihydroguaiaretic acid, NDGA) on canine pancreatic allografts. Transplant Proc 23:1681-1682
9. Horichi H, Izumi R, Shimizu K, Konishi K, Kitabayashi K, Watanabe T, Miyazaki I (1991) Effect of 5-lipoxygenase inhibitor on canine pancreatic allotransplantation. Transplant Proc 23: 1679-1680
10. 2 induces donor-specific tolerance in rat cadiac allograft recipients. Transplantation 51:242-246
11. Anderson CB, Jeffee BM, Graff RJ (1977) Prolongation of murine skin allografts by prostaglandin E. Transplantation 23:444-447
12. Mangino MJ, Jendrisak MD, Brunt E, Anderson CB (1988) Eicosanoid synthesis inhibition and renal allograft function during acute rejection. Transplantation 45:902-907
13. Perez RV, Babcock GF, Alexander JW (1989) Immunoregulation of transfusion-induced immunosuppression with inhibitors of the arachidonic acid metabolism. Transplantation 48:85-87
14. Goodwin JS, Bankhurst AD, Messner RP (1977) Suppression of human T-cell mitogenesis by prostaglandin. J Exp Med 146:1719-1734
15. Jordan ML, Hoffman RA, Debe EF, West MA, Simmons RL (1987) Prostaglandin E, mediates subset-specific effects on the functional responses of allosensitized T lymphocyte clones. Transplantation 43:117-123
16. Rappaport RS, Dogde GR (1982) Prostaglandin E inhibits the production of human interleukin 2. J Exp Med 155:943-948
17. Synder DS, Beller DI, Unanue ER (1982) Prostaglandins modulate macrophage Ia expression. Nature 299:163-165
18. Payan DG, Goldman DW, Goetzl EJ (1984) Biochemical and cellular characteristics of the regulation of human leukocyte function by lipoxygenase products of arachidonic acid. In: Charkrin LW, Bailey DM (eds) The leukotrienes, chemistry and biology. Academic, Orlando, pp 231-245
19. Smith MJH, Ford-Hutchinson AW, Bray MA (1980) Leukotriene B: a potential mediator of inflammation. J Pharm Pharmacol 32:517-518
20. 4 causes proliferation of interleukin 2-dependent T cells in the presence of suboptimal levels of interleukin 2. Cell Immunol 99:444-452
21. 4) augments IL2-dependent proliferation of T lymphocyte clones. Transplant Proc 18:224-227
22. Pleszczynski MR, Lemaire I (1985) Leukotrienes augment interleukin 1 production by human monocytes. J Immunol 135: 3958-3961
23. 4 in human lymphocyte cultures. Prostaglandins Leukot Essent Fatty Acids 23:207-210
24. 4 augments human natural cytotoxic cell activity. Biochem Biophys Res Commun 113:531-537
25. 4 in vitro. Biochem Biophys Res Commun 104:1617-1622
26. Johnson HM, Torres BA (1984) Leukotrienes: positive signals for regulation of γ-interferon production. J Immunol 132:413-416
27. 4 in man. Allergy 41:365-372
28. Dahlen SE, Bjork J, Hedqvist P, Arfors KE, Hammarstrom S, Lindgren JA, Samuelsson B (1981) Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: In vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci USA 78:3887-3891
29. Feuerstein G (1985) Autonomic pharmacology of leukotrienes. J Auton Pharmacol 5:149-168
30. Keppler D, Hagmann W, Rapp S, Denzlinger C, Koch HK (1985) The relation of leukotrienes to liver injury. Hepatology 5:883-891
31. Trudell JR, Bendix M, Bosterling B (1984) Hypoxia potentiates killing of hepatotyte monolayers by leukotrienes, hydroperoxyeicosatetraenoic acids, or calcium ionophore A23187. Biochem Biopys Acta 803:338-341
32. 2 and some drugs on an acute galactosamine induced liver damage in rat. Folia Histchem Cytobiol 18:311-317
33. Stachura J, Tarnawski A, Ivey KJ, Mach T, Bogdal J, Szczudrawa J, Klimczyk B (1981) Prostaglandin protection of carbon tetrachloride-induced liver cell necrosis in the rat. Gastroenterology 81:211-217
34. Iyobe T, Izumi R, Shimizu K (1993) The immunosuppressive effect of 5-lipoxigenase inhibitor on liver allotransplantation in rats. Transplantation 56:518-523
35. Yoshimoto T, Yokoyama C, Ochi K, Yumamoto S, Maki Y, Ashida Y, Terao S, Shiraishi M (1982) 2,3,5-trimethyl-6-(12-hydroxy-5.10-dodecadiynyl)-1,4-benzoquinone (AA861), a selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxis. Biochem Biophys Acta 713:470-473
36. Ashida Y, Saijo T, Kuriki H, Makino H, Terao S, Maki Y (1983) Pharmacological profile of AA-861, a 5-lipoxygenase inhibitor. Prostaglandins 26:955-972
37. 4 receptor antagonist. Adv Prostaglandin Thromboxane Leukot Res 21:407-410
38. 4-induced neutrophil functions. Prostaglandins 44:261-275
39. Kamada N, Calne RY (1979) Orthotopic liver transplantation in the rat. Transplantation 28:47-50
40. Kamada N, Sumimoto R, Kaneda K (1992) The value of hepatic artery reconstruction as a technique in rat liver transplantation. Surgery 111:195-200
41. David NA (1972) The pharmacology of dimethyl sulfoxide 6544. Annu Rev Pharmacol Toxicol 12:353-374
42. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265-275
43. Nonomura A, Mizukami Y, Matsubara F, Kobayashi K (1991) Clinicopathological study of lymphocyte attachment to endothelial cells (endothelialitis) in various liver diseases. Liver 11:78-87
44. Hagmann W, Steffan AM, Kim A, Keppler D (1987) Leukotrienes as mediators in frog virus 3-induced hepatitis in rats. Hepatology 7:732-736
45. 4 receptor antagonist against hypomagnesic diet-induced dermatitis in hairless rats. J Dermatol (Tokyo) 19:456-460
46. 4 receptor antagonist, SC-41930. Inflammation 14:727-739
47. Sinclair S, Levy G (1990) Eicosanoids and the liver. Ital J Gastroenterol 22:205-213
48. Koppler D, Huber M, Baumart T (1988) Leukotrienes as mediators in diseases of the liver. Sem Liv Dis 8:357-366
49. 4 20-hydroxylase from polymorphonuclear leukocytes. J Biol Chem 259:3082-3089
50. 4 in isolated rat hepatocytes. J Biol Chem 261:5414-5418
51. Crooke ST, Mong S, Sarau HM, Winkler JD, Vegesna VK (1988) Mechanisms of regulation of receptors and signal transduction pathways for the peptidyl leukotrienes. Ann New York Acad Sci 524:153-161
52. Ford-Hutchinson AW (1985) Leukotrienes: Their formation and role as inflammatory mediators. Fed Proc 44:25-29
53. 2. Adv Prostaglandin Thromboxane Res 3:105-112
54. 2. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 6th edn. MacMillan, New York, pp 668-681
55. 2+ mediates phagocytosis-evoked icosanoid synthesis in Kupffer cells. In: Braquet P, Garay RP, Frolich JC, Nicosia S (eds) Prostaglandins and membrane ion transport. Raven, New York, pp 113-118
56. 4 release from activated neutrophils. Proc Natl Acad Sci USA 80:4349-4353